Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Generation Bio Co

GBIO
Current price
1.39 USD +0.26 USD (+23.01%)
Last closed 1.13 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 91 848 416 USD
Yield for 12 month -73.37 %
Week
Month
Year
GBIO
21.11.2021 - 28.11.2021

Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was formerly known as Torus Therapeutics, Inc. and changed its name to Generation Bio Co. in November 2017. Generation Bio Co. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts. Address: 301 Binney Street, Cambridge, MA, United States, 02142

Analytics

WallStreet Target Price

8.25 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

+2 146 000 USD

Last Quarter

+880 000 USD

Current Year

Last Year

Current Quarter

+2 146 000 USD

Last Quarter

+880 000 USD

Key Figures GBIO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -124 446 000 USD
Operating Margin TTM -1461.18 %
PE Ratio
Return On Assets TTM -20.68 %
PEG Ratio
Return On Equity TTM -45.81 %
Wall Street Target Price 8.25 USD
Revenue TTM 3 026 000 USD
Book Value 3.52 USD
Revenue Per Share TTM 0.048 USD
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings Share -1.97 USD
Diluted Eps TTM -1.97 USD
Most Recent Quarter III 2023
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics GBIO

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History GBIO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation GBIO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM 30.3531
Enterprise Value EBITDA 0.9222
Price Book MRQ 0.396

Financials GBIO

1 year
3 years
5 years
10 years
Results 2019 Dynamics

Technical indicators GBIO

For 52 weeks

0.86 USD 7.35 USD
50 Day MA 1.97 USD
Shares Short Prior Month 1 747 280
200 Day MA 3.95 USD
Short Ratio 2.39
Shares Short 3 092 833
Short Percent 8.01 %